Now live: Pro — the full 13F research suite for serious investorsSee pricing →
UNIVERSITY OF CHICAGO

Q4 2024 · 13F-HR

UNIVERSITY OF CHICAGOholdings as filed

Filed 2025-02-05 · accession 0001104659-25-009415

$106.5M
Reported value
5
Positions
2024-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
921937835BNDVANGUARD BD INDEX FDS TOTAL BND MRKT$39.8M37.3%552,830CommonSOLE
922042742VTVANGUARD INTL EQUITY INDEX F$33.5M31.5%285,449CommonSOLE
922908363VOOVANGUARD INDEX FDS$32.8M30.8%60,891CommonSOLE
65488A101NKGNNKGEN BIOTECH INC$360,3600.34%550,000CommonSOLE
747324101PYXSPYXIS ONCOLOGY INC$76,0200.07%48,731CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.